Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain

This study has been completed.

Study NCT00343733 Information provided by Cephalon

First Received: June 21, 2006 Last Updated: November 9, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2007
Estimated Primary Completion Date:	No date given